Astec Lifesciences Ltd | Industry : (Agro Chemicals) | |
---|---|---|
BSE Code : 533138 |
NSE Symbol : ASTEC |
P/E(TTM) : - |
ISIN Demat : INE563J01010 |
Div & Yield% : 0.12 |
EPS(TTM) : - |
Book Value(₹) : 187.99 |
Market Cap(₹Cr) : 2,418.77 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 69.37 | 153.75 | 50.79 | 110.79 | 142.85 | 126.97 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 69.37 | 153.75 | 50.79 | 110.79 | 142.85 | 126.97 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 0.91 | 2.03 | 0.90 | 0.96 | 1.70 | 2.57 |
Total Income | 70.28 | 155.78 | 51.69 | 111.74 | 144.55 | 129.54 |
Total Expenditure | 115.62 | 141.04 | 69.12 | 114.21 | 139.71 | 121.57 |
PBIDT | -45.34 | 14.74 | -17.43 | -2.46 | 4.83 | 7.97 |
Interest | 7.05 | 6.68 | 6.10 | 6.00 | 6.47 | 6.41 |
PBDT | -52.39 | 8.06 | -23.53 | -8.46 | -1.63 | 1.56 |
Depreciation | 9.28 | 9.02 | 8.72 | 9.17 | 9.40 | 7.77 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.02 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -21.93 | 0.03 | -7.90 | -4.19 | -2.83 | -0.19 |
Reported Profit After Tax | -39.74 | -0.99 | -24.35 | -13.45 | -8.21 | -5.00 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | -39.74 | -0.99 | -24.35 | -13.45 | -8.21 | -5.00 |
EPS (Unit Curr.) | -20.26 | -0.50 | -12.42 | -6.86 | -4.19 | -2.55 |
EPS (Adj) (Unit Curr.) | -20.26 | -0.50 | -12.42 | -6.86 | -4.19 | -2.55 |
Calculated EPS (Unit Curr.) | -20.26 | -0.50 | -12.42 | -6.86 | -4.19 | -2.55 |
Calculated EPS (Adj) (Unit Curr.) | -20.26 | -0.50 | -12.42 | -6.86 | -4.19 | -2.55 |
Calculated EPS (Ann.) (Unit Curr.) | -81.05 | -2.02 | -49.66 | -27.43 | -16.74 | -10.19 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | -81.05 | -2.02 | -49.66 | -27.43 | -16.74 | -10.19 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 19.61 | 19.61 | 19.61 | 19.61 | 19.61 | 19.61 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | -65.36 | 9.59 | -34.32 | -2.22 | 3.38 | 6.28 |
PBDTM(%) | -75.52 | 5.24 | -46.33 | -7.64 | -1.14 | 1.23 |
PATM(%) | -57.29 | -0.64 | -47.94 | -12.14 | -5.75 | -3.94 |